Publication:
Occupational practice in patients with hereditary transthyretin amyloidosis, a qualitative study

dc.contributor.authorGayà-Barroso, Aina
dc.contributor.authorGonzález-Moreno, Juan
dc.contributor.authorRodríguez, Adrián
dc.contributor.authorRipoll-Vera, Tomás
dc.contributor.authorLosada-López, Inés
dc.contributor.authorGili, Margarita
dc.contributor.authorPaneque, Milena
dc.contributor.authorPérez-Martínez, Sara
dc.contributor.authorCisneros-Barroso, Eugenia
dc.date.accessioned2024-10-09T06:35:22Z
dc.date.available2024-10-09T06:35:22Z
dc.date.issued2023-11-10
dc.description.abstractBackground: Hereditary transthyretin amyloidosis (ATTRv) is a rare genetic disease that negatively affects patients' quality of life through the involvement of various organs and tissues. Despite a large amount of research on medical and psychosocial interventions, the impact of occupational therapy (OT) on patients with ATTRv is not well understood. Objective: The aim of this study was to develop an OT programme to improve the daily functioning and quality of life of patients with ATTRv. Methods: Fourteen patients with ATTRv were interviewed. Together they developed short- and medium-term occupational goals. Patients received the OT intervention for six months. Outcomes were measured using scores for activities of daily living and psychological well-being. Results: The study found that OT can have a positive impact as a complementary intervention to medical and other psychosocial treatments. Of the 14 patients, 12 maintained the same scores in activities of daily living. Two deteriorated and eight improved their psychological scores. Conclusion: This study highlights the need for further research in this area and the importance of OT in the management of patients with ATTRv. Early intervention is of paramount importance and further research is needed to evaluate the long-term effects of OT interventions in patients with ATTRv.en
dc.description.sponsorshipThis study was supported by an independent research grant (ID#64965375) from Pfizer Spain. Pfizer Spain did not have any influence on study design, data processing, or statistical analysis.es_ES
dc.format.number1es_ES
dc.format.page352es_ES
dc.format.volume18es_ES
dc.identifier.citationGayà-Barroso A, González-Moreno J, Rodríguez A, Ripoll-Vera T, Losada-López I, Gili M, et al. Occupational practice in patients with hereditary transthyretin amyloidosis, a qualitative study. Orphanet J Rare Dis. 2023 Nov 10;18(1):352.en
dc.identifier.doi10.1186/s13023-023-02964-3
dc.identifier.e-issn1750-1172es_ES
dc.identifier.journalOrphanet journal of rare diseaseses_ES
dc.identifier.otherhttps://hdl.handle.net/20.500.13003/19990
dc.identifier.pubmedID37950297es_ES
dc.identifier.puiL2026563820
dc.identifier.urihttps://hdl.handle.net/20.500.12105/23729
dc.language.isoengen
dc.publisherBioMed Central (BMC)
dc.relation.publisherversionhttps://doi.org/10.1186/s13023-023-02964-3en
dc.rights.accessRightsopen accessen
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.decsNeuropatías Amiloides Familiares*
dc.subject.decsHumanos*
dc.subject.decsCalidad de Vida*
dc.subject.decsActividades Cotidianas*
dc.subject.decsInvestigación Cualitativa*
dc.subject.decsEnfermedades Raras:*
dc.subject.meshActivities of Daily Living*
dc.subject.meshQuality of Life*
dc.subject.meshRare Diseases*
dc.subject.meshHumans*
dc.subject.meshQualitative Research*
dc.subject.meshAmyloid Neuropathies, Familial*
dc.titleOccupational practice in patients with hereditary transthyretin amyloidosis, a qualitative studyen
dc.typeresearch articleen
dspace.entity.typePublication
relation.isPublisherOfPublication4fe896aa-347b-437b-a45b-95f4b60d9fd3
relation.isPublisherOfPublication.latestForDiscovery4fe896aa-347b-437b-a45b-95f4b60d9fd3

Files